MME and endometrioid stromal sarcoma: Knowledge of medical history and the use of specific immunostains (e.g., CD10 and estrogen receptors for endometrial stromal sarcoma) and/or molecular markers (e.g., SYT rearrangement for synovial sarcoma) consistently enable a definitive diagnosis.